 Dapsone single agent suboptimal therapy Pneumocystis carinii pneumonia prospective noncomparative study patients mild Pneumocystis carinii pneumonia room air arterial mm Hg time presentation dapsone dose mg patients required mechanical ventilation respiratory failure day dapsone therapy patients experienced major side effects dapsone therapy None patients full course therapy dapsone high-dose single-agent dapsone suitable study therapy Pneumocystis carinii pneumonia